These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25873167)

  • 41. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
    Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
    Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined inhibition of menin-MLL interaction and TGF-β signaling induces replication of human pancreatic beta cells.
    Pahlavanneshan S; Behmanesh M; Oropeza D; Furuyama K; Tahamtani Y; Basiri M; Herrera PL; Baharvand H
    Eur J Cell Biol; 2020 Jun; 99(5):151094. PubMed ID: 32646642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MLL1 and menin: not partners in crime?
    Djabali M
    Blood; 2013 Sep; 122(12):1995. PubMed ID: 24052538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF/p75).
    Méreau H; De Rijck J; Cermáková K; Kutz A; Juge S; Demeulemeester J; Gijsbers R; Christ F; Debyser Z; Schwaller J
    Leukemia; 2013 Jun; 27(6):1245-53. PubMed ID: 23318960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
    Muntean AG; Hess JL
    Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular mechanisms of MLL-associated leukemia.
    Yokoyama A
    Int J Hematol; 2015 Apr; 101(4):352-61. PubMed ID: 25773519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of M-1121 as an Orally Active Covalent Inhibitor of Menin-MLL Interaction Capable of Achieving Complete and Long-Lasting Tumor Regression.
    Zhang M; Aguilar A; Xu S; Huang L; Chinnaswamy K; Sleger T; Wang B; Gross S; Nicolay BN; Ronseaux S; Harvey K; Wang Y; McEachern D; Kirchhoff PD; Liu Z; Stuckey J; Tron AE; Liu T; Wang S
    J Med Chem; 2021 Jul; 64(14):10333-10349. PubMed ID: 34196551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid Leukemia.
    Ghisi M; Kats L; Masson F; Li J; Kratina T; Vidacs E; Gilan O; Doyle MA; Newbold A; Bolden JE; Fairfax KA; de Graaf CA; Firth M; Zuber J; Dickins RA; Corcoran LM; Dawson MA; Belz GT; Johnstone RW
    Cancer Cell; 2016 Jul; 30(1):59-74. PubMed ID: 27374225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chromatin modifications as therapeutic targets in MLL-rearranged leukemia.
    Deshpande AJ; Bradner J; Armstrong SA
    Trends Immunol; 2012 Nov; 33(11):563-70. PubMed ID: 22867873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program.
    Xu J; Li L; Xiong J; denDekker A; Ye A; Karatas H; Liu L; Wang H; Qin ZS; Wang S; Dou Y
    Cell Discov; 2016; 2():16008. PubMed ID: 27462455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disruption of the menin-MLL interaction triggers menin protein degradation via ubiquitin-proteasome pathway.
    Wu Y; Doepner M; Hojnacki T; Feng Z; Katona BW; He X; Ma J; Cao Y; Busino L; Zhou F; Hua X
    Am J Cancer Res; 2019; 9(8):1682-1694. PubMed ID: 31497350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-based screening and optimization of cytisine derivatives as inhibitors of the menin-MLL interaction.
    Zhong HJ; Lee BR; Boyle JW; Wang W; Ma DL; Hong Chan PW; Leung CH
    Chem Commun (Camb); 2016 Apr; 52(34):5788-91. PubMed ID: 27004852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design of Inhibitors That Target the Menin-Mixed-Lineage Leukemia Interaction.
    Arthur MN; Bebla K; Broni E; Ashley C; Velazquez M; Hua X; Radhakrishnan R; Kwofie SK; Miller WA
    Computation (Basel); 2024 Jan; 12(1):. PubMed ID: 38938622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target.
    Brzezinka K; Nevedomskaya E; Lesche R; Haegebarth A; Ter Laak A; Fernández-Montalván AE; Eberspaecher U; Werbeck ND; Moenning U; Siegel S; Haendler B; Eheim AL; Stresemann C
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of combined CDK9/BET inhibition in preclinical models of MLL-rearranged acute leukemia.
    McCalmont H; Li KL; Jones L; Toubia J; Bray SC; Casolari DA; Mayoh C; Samaraweera SE; Lewis ID; Prinjha RK; Smithers N; Wang S; Lock RB; D'Andrea RJ
    Blood Adv; 2020 Jan; 4(2):296-300. PubMed ID: 31971998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein-Ligand Complexes.
    Pollock J; Borkin D; Lund G; Purohit T; Dyguda-Kazimierowicz E; Grembecka J; Cierpicki T
    J Med Chem; 2015 Sep; 58(18):7465-74. PubMed ID: 26288158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Theoretical models of inhibitory activity for inhibitors of protein-protein interactions: targeting menin-mixed lineage leukemia with small molecules.
    Jedwabny W; Kłossowski S; Purohit T; Cierpicki T; Grembecka J; Dyguda-Kazimierowicz E
    Medchemcomm; 2017 Dec; 8(12):2216-2227. PubMed ID: 29456828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Shp2 regulates leukemic stem cell frequency in MLL-rearranged acute myeloid leukemia.
    Wu J
    Stem Cell Investig; 2015; 2():7. PubMed ID: 27358875
    [No Abstract]   [Full Text] [Related]  

  • 59. Menin inhibitors seek to debut as newest targeted therapy for leukaemia.
    Garber K
    Nat Rev Drug Discov; 2024 Aug; 23(8):567-569. PubMed ID: 38906988
    [No Abstract]   [Full Text] [Related]  

  • 60. Potential Treatment of Acute Leukemia with Inhibitors of Menin/MLL Interaction.
    Abdel-Magid AF
    ACS Med Chem Lett; 2018 Sep; 9(9):868-869. PubMed ID: 30258531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.